116 related articles for article (PubMed ID: 6810502)
21. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
[TBL] [Abstract][Full Text] [Related]
22. Urinary glycosaminoglycan excretion in rheumatic diseases.
Kéry V; Orlovská M; Stancíková M; Risko M; Zlnay D
Clin Chem; 1992 Jun; 38(6):841-6. PubMed ID: 1597009
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
Michelacci YM; Glashan RQ; Schor N
Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
[TBL] [Abstract][Full Text] [Related]
24. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis.
Mbuyi JM; Dequeker J; Teblick M; Merlevede M
J Rheumatol; 1982; 9(4):579-83. PubMed ID: 7131456
[TBL] [Abstract][Full Text] [Related]
25. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
[TBL] [Abstract][Full Text] [Related]
26. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
27. Urinary proteoglycan degradation product excretion in patients with rheumatoid arthritis and osteoarthritis.
Krajícková J; Macek J
Ann Rheum Dis; 1988 Jun; 47(6):468-71. PubMed ID: 3382265
[TBL] [Abstract][Full Text] [Related]
28. [Excretion of various glycosaminoglycans in patients with chronic duodenal ulcer].
Isaev MN; Rabinovich PD
Vopr Med Khim; 1988; 34(1):62-5. PubMed ID: 3369127
[TBL] [Abstract][Full Text] [Related]
29. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
30. A simple method for the quantitation of glycuronic acid-containing glycosaminoglycans with mucopolysaccharidases.
Yosizawa Z; Ototani N; Satake S
Anal Biochem; 1983 Jan; 128(1):250-6. PubMed ID: 6846797
[TBL] [Abstract][Full Text] [Related]
31. [A histochemical study on the acidic glycoconjugates of the synovial membrane in rheumatoid arthritis].
Okuda T; Hirabayashi Y
Nihon Seikeigeka Gakkai Zasshi; 1994 Apr; 68(4):196-206. PubMed ID: 8189101
[TBL] [Abstract][Full Text] [Related]
32. Simple spectrophotometric quantification of urinary excretion of glycosaminoglycan sulfates.
Panin G; Naia S; Dall'Amico R; Chiandetti L; Zachello F; Catassi C; Felici L; Coppa GV
Clin Chem; 1986 Nov; 32(11):2073-6. PubMed ID: 3096595
[TBL] [Abstract][Full Text] [Related]
33. Abnormal urinary excretion of glycosaminoglycans in Albers-Schönberg disease.
Marcucci F; Rufini S; Sensi L
Clin Chim Acta; 1982 Apr; 120(2):161-70. PubMed ID: 7067142
[TBL] [Abstract][Full Text] [Related]
34. Fluorometric measurement of urinary alpha-L-iduronidase activity.
Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
[TBL] [Abstract][Full Text] [Related]
35. Urinary excretion of acid glycosaminoglycans and hydroxyproline in a patient with oculo-cerebro-renal syndrome.
Hayashi S; Nagata T; Kimura A; Tsurumi K
Tohoku J Exp Med; 1978 Nov; 126(3):215-23. PubMed ID: 734646
[TBL] [Abstract][Full Text] [Related]
36. Increased urinary excretion of glycosaminoglycans in insulin-dependent diabetic patients with limited joint mobility.
Priestley GC; Collier A; Matthews DM; Clarke BF
Br J Rheumatol; 1988 Dec; 27(6):462-4. PubMed ID: 3203190
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biochemical effects of long-term vitamin A administration to a patient with Hurler-Scheie compound.
Wannmacher CM; Wajner M; Giugliani R; Costa MG; Giugliani ER; Castro JZ
Braz J Med Biol Res; 1984; 17(1):43-7. PubMed ID: 6236861
[TBL] [Abstract][Full Text] [Related]
38. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.
Hennessey PT; Hurst RE; Hemstreet GP; Cutter G
Cancer Res; 1981 Oct; 41(10):3868-73. PubMed ID: 6793229
[TBL] [Abstract][Full Text] [Related]
39. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome.
Pereira DA; Aguiar JA; Hagiwara MK; Michelacci YM
Biochim Biophys Acta; 2004 Apr; 1672(1):1-11. PubMed ID: 15056487
[TBL] [Abstract][Full Text] [Related]
40. The effect of fasting and time of day on the urinary excretion of chondroitin 4/6 sulphate, dermatan sulphate and four chondroitinase ABC resistant glycosaminoglycans.
Poulsen JH; Gregersen H
Scand J Clin Lab Invest; 1983 Dec; 43(8):665-70. PubMed ID: 6420878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
